Specific Substances: Sulfamethizole
Nomination Date: 10/22/1984
Rationale: Sulfamethizole has produced a low incidence of sarcomas in preliminary studies in mice. It is believed to have considerable potential for human exposure based on its use as a major sulfa drug in the treatment of urinary tract infections.
NTP Principles: Pre 1993 - 6,
Status: In Review/Pending